Prosecution Insights
Last updated: April 19, 2026

Hepagene Therapeutics (Hk) Limited

1 pending office actions

Portfolio Summary

1
Total Pending OAs
1
Final Rejections
0
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
17601403 BIVALENT ANTAGONISTS OF INHIBITORS OF APOPTOSIS PROTEINS KATAKAM, SUDHAKAR 1658 Final Rejection Oct 04, 2021

Managing Hepagene Therapeutics (Hk) Limited's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month